Antihemorrhagics
Antihemoragiká
Slovakia · Žilina · how to bid here →
Your path to submission
- Deadline: 29 October at 09:00 — 26 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: SLK, SLK, SLK, SLK, SLK, SLK, SLK.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (116 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to INTRAVENA s.r.o..n = 116
- 44% of this buyer's awards went to companies that had already won here before (206 awards since 2018, spread over 37 companies). That is well below the sector norm (63%) — this buyer switches suppliers more often than others.n = 206 awards since 2018
- 47% of the bids received came from small and medium-sized enterprises (127 procedures with a bid mix). Sector: 72%.n = 127
- The median procedure drew 2 bids (189 procedures with a bid count); 30% ended with a single bidder. Sector: median 2 bids.n = 189
- The award came in at a median 94% of the estimated value (32 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 91%.n = 32
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 29/09/2026.
Foreign bidders
In Slovakia · Medical equipment & pharma, 17 contracts went to foreign companies over the last 3 years (of 1,850 recorded awards).
Submission language: SLK.
Typical field: median 2 (from 116 awards).
What the buyer is looking for
Antihaemorrhagics for the needs of individual FNsP departments. · Part 1 Phytomenadione oral 1x5 ml/100 mg 140 Phytomenadione parenteral 1x1 ml/10 mg 12000 Etamsylate parenteral 1x2 ml/250 mg 17200 Etamsylate oral 1x500 mg 1800 · Part 2 Tranexamic acid parenteral 1x5 ml (100 mg/ml) 8000 · Part 3 Human fibrinogen parenteral 1x1 g 50 · Part 4 Human fibrinogen parenteral 1x1 g 50 (treatment of severe bleeding in patients with acquired hypofibrinogenemia during surgery) · Part 5 Coagulation factor IX, II, VII and X in combinatio parenteral 1x500 IU+solv. 120 · Part 6 Romiplostim parenterally 1x250 μg + 0.72 ml solv. 160 · Part 7 Alpha1 antitrypsin parenterally 1x1000 mg + 1x20 ml solv. 208
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Slovak.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| MED - ART, spol. s r.o. | 28 | 2024–2026 |
| UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť | 21 | 2024–2026 |
| INTRAVENA s.r.o. | 9 | 2024–2026 |
| B. Braun Medical s.r.o. | 9 | 2024–2026 |
| Surgitech s. r. o. | 7 | 2025–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.